Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$8.12 -0.21 (-2.52%)
At close: Oct 1, 2026 · 4:00 PM EDT

Biocryst Pharmaceuticals (BCRX) Other Operating Expenses (2012 - 2026)

Updated

Biocryst Pharmaceuticals (BCRX) reported Other Operating Expenses of $3.84 million for Q2 2026, up 37.2% from $2.8 million a year earlier but down 99.5% from the prior quarter.

Analysis

Biocryst Pharmaceuticals (BCRX) Other Operating Expenses (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Biocryst Pharmaceuticals' Other Operating Expenses came in at $718.69 million; for FY2025, it was $19.08 million, up 55.5% from FY2024.

  • Other Operating Expenses has a five-year compound annual growth rate of 172.9% (FY2020 to FY2025).
  • By year, Other Operating Expenses came in at $12.27 million in FY2024 (+173.8%), $4.48 million in FY2023 (-32.0%), $6.59 million in FY2022 (-9.2%) and $7.26 million in FY2021.
  • Five-year quarterly Other Operating Expenses spans a low of $238,000 in Q1 2022 and a high of $703.14 million in Q1 2026.
  • Year over year, Other Operating Expenses gained in six of the last seven quarters, with growth averaging 126.9%.
  • The high point for year-over-year Other Operating Expenses in five years was Q4 2021 (growth of 772.9%); the low point was Q1 2022 (a decline of 96.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $703.14 million (Q1 2026), $9.52 million (Q4 2025) and $2.19 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Biocryst Pharmaceuticals 2.13 Bn 1.05 Bn 214.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.84 Mn
Mar 31, 2026 703.14 Mn
Dec 31, 2025 9.52 Mn
Sep 30, 2025 2.19 Mn
Jun 30, 2025 2.80 Mn
Mar 31, 2025 4.57 Mn
Dec 31, 2024 6.09 Mn
Sep 30, 2024 3.21 Mn
Jun 30, 2024 1.70 Mn
Mar 31, 2024 1.27 Mn
Dec 31, 2023 1.46 Mn
Sep 30, 2023 1.14 Mn
Jun 30, 2023 950,000.00
Mar 31, 2023 938,000.00
Dec 31, 2022 2.50 Mn
Sep 30, 2022 3.61 Mn
Jun 30, 2022 247,000.00
Mar 31, 2022 238,000.00
Dec 31, 2021 419,000.00
Sep 30, 2021 615,000.00
API Access

Biocryst Pharmaceuticals Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BCRX&period=max&api_key=YOUR_API_KEY